LENZ Therapeutics, Inc. (LENZ)
NASDAQ · Healthcare
LENZ Therapeutics, Inc. EBITDA 2024–2025
LENZ Therapeutics, Inc. annual/quarterly ebitda history and growth rate from 2024 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- LENZ Therapeutics, Inc. ebitda for the quarter ending March 31, 2026 was -44.0 M, a 160.57% increase year-over-year.
- LENZ Therapeutics, Inc. annual ebitda for 2025 was -90.9 M, a 55.16% increase from 2024.
- LENZ Therapeutics, Inc. annual ebitda for 2024 was -58.6 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
LENZ Therapeutics, Inc. EBITDA — FAQ
LENZ Therapeutics, Inc. (LENZ) ebitda over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LENZ's ebitda history?
The chart and table above show LENZ Therapeutics, Inc.'s ebitda by year and by quarter, including the growth rate.